Consecutive Uncontrolled Gastrointestinal Immune-Related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma: A Case Report
Caution is essential when re-administering immune-checkpoint inhibitors to patients with prior irAEs, although upper gastrointestinal irAEs are usually manageable.
Authors
- Takayuki Nagao
- Hirofumi Chiba (ORCID: https://orcid.org/0000-0002-7033-3084)
- Yoshinori Toshima
- Keiki Yokoo (ORCID: https://orcid.org/0009-0008-8576-4750)
- Gen Yamada (ORCID: https://orcid.org/0000-0001-6160-2660)
- Satoshi Ota
- Kaori Kamata
Institutions
- Sapporo Medical University (JP)
- Teine Keijinkai Hospital (JP)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1159/000546295
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00